-
Galectin Therapeutics (GALT) PT Raised to $8 at Roth Capital
-
Galectin Therapeutics (GALT) PT Raised to $10 at Roth Capital
-
Roth Capital Starts Galectin Therapeutics (GALT) at Buy
-
Roth Capital Downgrades Galectin Therapeutics (GALT) to Sell
-
Galectin Therapeutics (GALT) Prices 4.76M Securities Purchase Agreement
-
Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering
-
Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering
-
Pre-Open Stock Movers 08/13: (PLNR) (SUNE) (CSCO) Higher; (BGMD) (SHAK) (KSS) Lower (more...)
-
Pre-Open Stock Movers 3/25: (GALT) (ECYT) (RAX) Higher; (IDN) (HIMX) (GIII) Lower (more...)

